-
Psychotic Experiences and Risk of Suicidal Thoughts and Behaviors: A Systematic Review and Meta-Analysis of Longitudinal Population Studies Schizophr. Bull. (IF 5.3) Pub Date : 2024-11-17 Kirstie O’Hare, Kubra Fadiloglu, Ulla Lång, Colm Healy, Mary Cannon, Jordan DeVylder, Ian Kelleher
Background and Hypothesis Since a prior systematic review and meta-analysis reported an association between psychotic experiences (PEs) and suicidal thoughts and behaviors, a large number of new studies have been published on the topic, including several novel studies on the association between PEs and transition from suicidal ideation to attempt. Study Design Two authors independently searched PubMed
-
Mitochondrial Dysfunction and Cognitive Impairment in Schizophrenia: The Role of Inflammation Schizophr. Bull. (IF 5.3) Pub Date : 2024-11-13 Guanyu Wang, Senqi Liu, Xiaoyun Fan, Jinming Li, Qianzi Xue, Kang Liu, Xue Li, Yongfeng Yang, Xiujuan Wang, Meng Song, Minglong Shao, Wenqiang Li, Yong Han, Luxian Lv, Xi Su
Background and Hypothesis The complex immune-brain interactions and the regulatory role of mitochondria in the immune response suggest that mitochondrial damage reported in schizophrenia (SZ) may be related to abnormalities observed in immune and brain functions. Study Design Mitochondrial DNA copy number (mtDNA CN), a biomarker of mitochondrial function, was assessed in peripheral blood leukocytes
-
Protective Factors Predict Resilient Outcomes in Clinical High-Risk Youth with the Highest Individualized Psychosis Risk Scores Schizophr. Bull. (IF 5.3) Pub Date : 2024-11-02 Kristin S Cadenhead, Jean Addington, Carrie E Bearden, Tyrone D Cannon, Barbara A Cornblatt, Matcheri Keshavan, Daniel H Mathalon, Diana O Perkins, William Stone, Elaine F Walker, Scott W Woods
Background and Hypothesis Studying individuals at Clinical High Risk (CHR) for psychosis provides an opportunity to examine protective factors that predict resilient outcomes. Here, we present a model for the study of protective factors in CHR participants at the very highest risk for psychotic conversion based on the Psychosis Risk Calculator. Study Design CHR participants (N = 572) from NAPLS3 were
-
The Effects of Cognitive Remediation on Negative Symptoms in Schizophrenia-Spectrum Illness: A Meta-analytic Investigation of Efficacy Schizophr. Bull. (IF 5.3) Pub Date : 2024-11-01 Grace Melville, Clara Preisig, Michael Zheng, Matthew M Kurtz
Background and Hypothesis The number of clinical efficacy trials of Cognitive Remediation (CR), a behavioral intervention consisting of cognitive task practice and/or strategy training to improve cognitive skills in schizophrenia, has increased substantially over the past 25 years. While recent reviews have highlighted the effects of CR on cognition and function, CR effects on negative symptoms remain
-
Molecular Evidence for Altered Angiogenesis in Neuroinflammation-Associated Schizophrenia and Bipolar Disorder Implicate an Abnormal Midbrain Blood-Brain Barrier Schizophr. Bull. (IF 5.3) Pub Date : 2024-10-29 Yunting Zhu, Maree J Webster, Gerardo Mendez Victoriano, Frank A Middleton, Paul T Massa, Cynthia Shannon Weickert
Background and Hypothesis Angiogenesis triggered by inflammation increases BBB permeability and facilitates macrophage transmigration. In the midbrain, we have discovered molecular alterations related to the blood-brain barrier (BBB), including endothelial cell changes associated with macrophage diapedesis, in neuroinflammatory schizophrenia and bipolar disorder, but changes in angiogenesis are yet
-
Sex Differences in Subclinical Psychotic Experiences: The Role of Daily-Life Social Interactions Schizophr. Bull. (IF 5.3) Pub Date : 2024-10-21 Zeynep Akcaoglu, Inez Myin-Germeys, Thomas Vaessen, Julie J Janssens, Martien Wampers, Eva Bamps, Ginette Lafit, Olivia J Kirtley, Robin Achterhof
Background and Hypothesis Sex differences in psychosis are reported across the psychosis spectrum, including in subclinical stages. An important factor in understanding these variations is the subjective experience of everyday social interactions (SI). We investigated whether the presence of psychotic experiences (PEs), as well as associated distress, differs between men and women. We focused on the
-
Clinician-Reported Negative Symptom Scales: A Systematic Review of Measurement Properties Schizophr. Bull. (IF 5.3) Pub Date : 2024-10-18 Lucia Weigel, Sophia Wehr, Silvana Galderisi, Armida Mucci, John M Davis, Stefan Leucht
Background Negative symptoms of schizophrenia are correlated with reduction of normal function and lower quality of life. They were newly defined by the NIMH-MATRICS Consensus in 2005, dividing the rating tools to assess them into first-generation scales, developed before the Consensus, and second-generation scales, based on the recently introduced definitions. Methods The COnsensus-based Standards
-
Bistable Perception Discriminates Between Depressive Patients, Controls, Schizophrenia Patients, and Their Siblings Schizophr. Bull. (IF 5.3) Pub Date : 2024-10-18 Elahe Arani, Simona Garobbio, Maya Roinishvili, Eka Chkonia, Michael H Herzog, Richard J A van Wezel
Background and Hypothesis Individuals with schizophrenia have less priors than controls, meaning they rely less upon their prior experiences to interpret the current stimuli. These differences in priors are expected to show as higher alternation rates in bistable perception tasks like the Structure-from-Motion (SfM) paradigm. In this paradigm, continuously moving dots in two dimensions are perceived
-
Exploring the Interactions Between Psychotic Symptoms, Cognition, and Environmental Risk Factors: A Bayesian Analysis of Networks Schizophr. Bull. (IF 5.3) Pub Date : 2024-10-14 Minke J Bosma, Maarten Marsman, Jentien M Vermeulen, Karoline B S Huth, Lieuwe de Haan, Behrooz Z Alizadeh, Claudia J C Simons, Frederike Schirmbeck
Background and Hypothesis Psychotic disorders (PDs) have huge personal and societal impact, and efforts to improve outcomes in patients are continuously needed. Environmental risk factors (ERFs), especially modifiable risk factors, are important to study because they pose a target for intervention and prevention. No studies have investigated ERFs, cognition, and psychotic symptoms together in a network
-
Defining Urbanicity in the Context of Psychosis Research: A Qualitative Systematic Literature Review Schizophr. Bull. (IF 5.3) Pub Date : 2024-10-11 Franco Mascayano, Jiwon Lee, Xinyu Yang, Zeyu Li, Rodrigo Casanueva, Viviana Hernández, Javiera Burgos, Ana Carolina Florence, Lawrence H Yang, Ezra Susser
Background and Hypothesis Numerous studies have found that being born or raised in urban environments increases the odds of developing psychosis in Northern and Western Europe. However, available research from Southern Europe, Latin America, and Asia has reported null results. A limitation in most studies to date is the inadequate characterization of urban and rural life components that may contribute
-
Risk Factors for Late-Onset Psychosis: A Case-Control Study Schizophr. Bull. (IF 5.3) Pub Date : 2024-10-09 Joseph P Skinner, Ann K Shinn, Lauren V Moran
Background and Hypothesis The onset of schizophrenia occurs after the age of 40 in up to 20% of cases. We aim to depict risk factors for first-episode psychosis after the age of 40 by comparing late-onset psychosis (LOP) patients to healthy age-matched controls. Study Design In this case-control study using electronic health records, 142 individuals aged 40–65 years with an encounter for a first episode
-
Relapse Following Electroconvulsive Therapy for Schizophrenia: A Systematic Review and Meta-analysis Schizophr. Bull. (IF 5.3) Pub Date : 2024-10-05 Nobuatsu Aoki, Aran Tajika, Taro Suwa, Hirotsugu Kawashima, Kazuyuki Yasuda, Toshiyuki Shimizu, Niina Uchinuma, Hirotaka Tominaga, Xiao Wei Tan, Azriel H K Koh, Phern Chern Tor, Stevan Nikolin, Donel Martin, Masaki Kato, Colleen Loo, Toshihiko Kinoshita, Toshi A Furukawa, Yoshiteru Takekita
Background Evidence regarding schizophrenia relapse following acute electroconvulsive therapy (ECT) is sparse compared with that for depression, and we have no clear consensus on relapse proportions. We aimed to provide longitudinal information on schizophrenia relapse following acute ECT. Study Design This systematic review and meta-analysis included randomised controlled trials (RCTs) and observational
-
L’espace vécu and Its Perturbations in Schizophrenia: Systematic Review and Meta-analysis of Altered Body-Centric Metrics—Personal and Peripersonal Space Schizophr. Bull. (IF 5.3) Pub Date : 2024-10-03 Andrea Raballo, Michele Poletti, Francesco Bevione, Maria Carla Lacidogna, Antonio Preti
Subtle distortions of the experience of lived space have long been associated with schizophrenia. Although a body-centric transformation of space is considered an essential component of anomalous subjective experience in schizophrenia, its impact on the 2 major body-centric spatial constructs, that is, personal space (PS) and peripersonal space (PPS), is still not clear. This systematic review and
-
Emotion Processing and Its Relationship to Social Functioning and Symptoms in Psychotic Disorder: A Systematic Review and Meta-analysis Schizophr. Bull. (IF 5.3) Pub Date : 2024-10-03 Sean Murrihy, Kate Filia, Sue Cotton, Lisa Phillips, Sarah Youn, Anuradhi Jayasinghe, Anna Wrobel, Eslam M Bastawy, Kelly Allott, Amity Watson
Background Emotion processing (EP) is impaired in individuals with psychosis and associated with social functioning; however, it is unclear how symptoms fit into this relationship. The aim of this systematic review and meta-analysis was to examine interrelationships between EP, symptoms, and social functioning, test whether different symptom domains mediate the relationship between EP and social functioning
-
Efficacy of User Self-Led and Human-Supported Digital Health Interventions for People With Schizophrenia: A Systematic Review and Meta-Analysis Schizophr. Bull. (IF 5.3) Pub Date : 2024-09-28 Urska Arnautovska, Mike Trott, Kathryn Jemimah Vitangcol, Alyssa Milton, Ellie Brown, Nicola Warren, Stefan Leucht, Joseph Firth, Dan Siskind
Background Digital health interventions (DHIs) may enable low cost, scalable improvements in the quality of care for adults with schizophrenia. Given the fast-growing number of studies using these tools, this review aimed to assess the efficacy and feasibility of randomized controlled trials (RCTs) of DHIs among people with schizophrenia, focusing on human support. Design A systematic search of PubMed
-
Anhedonia Across and Beyond the Schizophrenia Spectrum Schizophr. Bull. (IF 5.3) Pub Date : 2024-09-26 Raymond C K Chan, Ling-ling Wang, Jia Huang, Yi Wang, Simon S Y Lui
Anhedonia refers to the diminished ability to experience pleasure, and is a core feature of schizophrenia (SCZ). The neurocognitive and neural correlates of anhedonia remain elusive. Based on several influential theoretical models for negative symptoms, this selective review proposed four important neurocognitive domains, which may unveil the neurobiological mechanisms of anhedonia. The authors critically
-
The Common Structure of the Major Psychoses: More Similarities Than Differences in the Network Structures of Schizophrenia, Schizoaffective Disorder, and Psychotic Bipolar Disorder Schizophr. Bull. (IF 5.3) Pub Date : 2024-09-11 Wen Shao, Melanie Simmonds-Buckley, Orestis Zavlis, Richard P Bentall
Background and Hypothesis There has been a century-long debate about whether the major psychoses (eg, bipolar disorder, schizophrenia, and schizoaffective disorder) are one disorder with various manifestations or different disease entities. Traditional approaches using dimensional models have not provided decisive findings. Here, we address this question by examining the network constellation of affective
-
Modeling the Determinants of Subjective Well-Being in Schizophrenia Schizophr. Bull. (IF 5.3) Pub Date : 2024-09-10 Jae Hoon Jeong, Jayoun Kim, Nuree Kang, Yong Min Ahn, Yong Sik Kim, Donghwan Lee, Se Hyun Kim
Background The ultimate goal of successful schizophrenia treatment is not just to alleviate psychotic symptoms, but also to reduce distress and achieve subjective well-being (SWB). We aimed to identify the determinants of SWB and their interrelationships in schizophrenia. Methods Data were obtained from 637 patients with schizophrenia enrolled in multicenter, open-label, non-comparative clinical trials
-
EEG-based Signatures of Schizophrenia, Depression, and Aberrant Aging: A Supervised Machine Learning Investigation Schizophr. Bull. (IF 5.3) Pub Date : 2024-09-09 Elif Sarisik, David Popovic, Daniel Keeser, Adyasha Khuntia, Kolja Schiltz, Peter Falkai, Oliver Pogarell, Nikolaos Koutsouleris
Background Electroencephalography (EEG) is a noninvasive, cost-effective, and robust tool, which directly measures in vivo neuronal mass activity with high temporal resolution. Combined with state-of-the-art machine learning (ML) techniques, EEG recordings could potentially yield in silico biomarkers of severe mental disorders. Hypothesis Pathological and physiological aging processes influence the
-
Modeling Decision-Making in Schizophrenia: Associations Between Computationally Derived Risk Propensity and Self-Reported Risk Perception Schizophr. Bull. (IF 5.3) Pub Date : 2024-09-07 Emma N Herms, Joshua W Brown, Krista M Wisner, William P Hetrick, David H Zald, John R Purcell
Background and Hypothesis Schizophrenia is associated with a decreased pursuit of risky rewards during uncertain-risk decision-making. However, putative mechanisms subserving this disadvantageous risky reward pursuit, such as contributions of cognition and relevant traits, remain poorly understood. Study Design Participants (30 schizophrenia/schizoaffective disorder [SZ]; 30 comparison participants
-
Psychosis Risk: Time to Look Empirically at a First-step Economical-pragmatic Way to Examine Anomalous Self-experience. Exploring the SQuEASE-11 Schizophr. Bull. (IF 5.3) Pub Date : 2024-09-07 Paul Møller, Barnaby Nelson, Patrick D McGorry, Cristina Mei, G Paul Amminger, Hok Pan Yuen, Melissa Kerr, Jessica Spark, Nicky Wallis, Andrea Polari, Shelley Baird, Kate Buccilli, Sarah-Jane A Dempsey, Natalie Ferguson, Melanie Formica, Marija Krcmar, Amelia L Quinn, Yohannes Mebrahtu, Arlan Ruslins, Rebekah Street, Lisa Dixon, Cameron Carter, Rachel Loewy, Tara A Niendam, Martha Shumway, Cassandra
Background Since the late 1990s, there has been a worldwide surge of scientific interest in the pre-psychotic phase, resulting in the introduction of several clinical tools for early detection. The predictive accuracy of these tools has been limited, motivating the need for methodological and perspectival improvements. The EASE manual supports systematic assessment of anomalous self-experience, and
-
Neurostructural, Neurofunctional, and Clinical Features of Chronic, Untreated Schizophrenia: A Narrative Review Schizophr. Bull. (IF 5.3) Pub Date : 2024-08-30 Biqiu Tang, Li Yao, Jeffrey R Strawn, Wenjing Zhang, Su Lui
Studies of individuals with chronic, untreated schizophrenia (CUS) can provide important insights into the natural course of schizophrenia and how antipsychotic pharmacotherapy affects neurobiological aspects of illness course and progression. We systematically review 17 studies on the neuroimaging, cognitive, and epidemiological aspects of CUS individuals. These studies were conducted at the Shanghai
-
Multitrait Genetic Analysis Identifies Novel Pleiotropic Loci for Depression and Schizophrenia in East Asians Schizophr. Bull. (IF 5.3) Pub Date : 2024-08-27 Yingchao Song, Linzehao Li, Yue Jiang, Bichen Peng, Hengxuan Jiang, Zhen Chao, Xiao Chang
Background and Hypothesis While genetic correlations, pleiotropic loci, and shared genetic mechanisms of psychiatric disorders have been extensively studied in European populations, the investigation of these factors in East Asian populations has been relatively limited. Study Design To identify novel pleiotropic risk loci for depression and schizophrenia (SCZ) in East Asians. We utilized the most
-
Experiencing Psychosis and Shame: A Systematic Review and Meta-analysis of the Strength and Patterns of Association Schizophr. Bull. (IF 5.3) Pub Date : 2024-08-23 Kimberley Davies, Julia M Lappin, Chloe Gott, Zachary Steel
Background and Hypothesis Shame has been linked to the experience of psychosis, with implications for clinical outcomes, however, a meta-analysis of the relationship has not yet been conducted. This systematic review and meta-analysis aimed to examine the strength of the association between shame and psychosis, and any variations between clinical and non-clinical populations and shame type (internal
-
Altered Use of Context During Visual Perception in Psychotic Psychopathology: A Neurophysiological Investigation of Tuned and Untuned Suppression During Contrast Perception Schizophr. Bull. (IF 5.3) Pub Date : 2024-08-16 Samuel D Klein, Collin D Teich, Victor J Pokorny, Eric Rawls, Cheryl A Olman, Scott R Sponheim
Background and Hypothesis The human visual system streamlines visual processing by suppressing responses to textures that are similar to their surrounding context. Surround suppression is weaker in individuals with schizophrenia (ISZ); this altered use of visuospatial context may relate to the characteristic visual distortions they experience. Study Design To understand atypical surround suppression
-
Understanding the Psychosis Spectrum Using a Hierarchical Model of Social Cognition Schizophr. Bull. (IF 5.3) Pub Date : 2024-08-09 Trevor F Williams, Amy E Pinkham, Vijay A Mittal
Background and Hypothesis Social cognitive impairments are central to psychosis, including lower severity psychosis-like experiences (PLEs). Nonetheless, progress has been hindered by social cognition’s poorly defined factor structure, as well as limited work examining the specificity of social cognitive impairment to psychosis. The present study examined how PLEs relate to social cognition in the
-
The Association Between Trajectories of Self-reported Psychotic Experiences and Continuity of Mental Health Care in a Longitudinal Cohort of Adolescents and Young Adults Schizophr. Bull. (IF 5.3) Pub Date : 2024-08-08 Suzanne E Gerritsen, Koen Bolhuis, Larissa S van Bodegom, Athanasios Maras, Mathilde M Overbeek, Therese A M J van Amelsvoort, Dieter Wolke, Giovanni de Girolamo, Tomislav Franić, Jason Madan, Fiona McNicholas, Moli Paul, Diane Purper-Ouakil, Paramala Santosh, Ulrike M E Schulze, Swaran P Singh, Cathy Street, Sabine Tremmery, Helena Tuomainen, Gwen C Dieleman, Esther Mesman
Background and Hypothesis Young people (YP) with psychotic experiences (PE) have an increased risk of developing a psychiatric disorder. Therefore, knowledge on continuity of care from child and adolescent (CAMHS) to adult mental health services (AMHS) in relation to PE is important. Here, we investigated whether the self-reported trajectories of persistent PE were associated with likelihood of transition
-
Measuring Cognitive Impairments Associated With Schizophrenia in Clinical Practice: Overview of Current Challenges and Future Opportunities Schizophr. Bull. (IF 5.3) Pub Date : 2024-08-01 Keith H Nuechterlein, Henry Nasrallah, Dawn Velligan
Background Cognitive impairment associated with schizophrenia (CIAS) negatively impacts daily functioning, quality of life, and recovery, yet effective pharmacotherapies and practical assessments for clinical practice are lacking. Despite the pivotal progress made with establishment of the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery
-
The Role of Defeatist Performance Beliefs in State Fluctuations of Negative Symptoms in Schizophrenia Measured in Daily Life via Ecological Momentary Assessment Schizophr. Bull. (IF 5.3) Pub Date : 2024-07-27 Lauren Luther, Ian M Raugh, Paul M Grant, Aaron T Beck, Gregory P Strauss
Background and Hypothesis: The Cognitive Model of Negative Symptoms is a prominent model that posits that defeatist performance beliefs (DPB) are a key psychological mechanism underlying negative symptoms in those with schizophrenia (SZ). However, the ecological validity of the model has not been established, and temporally specific evaluations of the model’s hypotheses have not been conducted. This
-
Timeframe for Conversion to Psychosis From Individuals at Clinical High-Risk: A Quantile Regression Schizophr. Bull. (IF 5.3) Pub Date : 2024-07-26 TianHong Zhang, YanYan Wei, XiaoChen Tang, LiHua Xu, YeGang Hu, HaiChun Liu, ZiXuan Wang, Tao Chen, ChunBo Li, JiJun Wang
Background and Hypothesis The time taken for an individual who is at the clinical high-risk (CHR) stage to transition to full-blown psychosis may vary from months to years. This temporal aspect, known as the timeframe for conversion to psychosis (TCP), is a crucial but relatively underexplored dimension of psychosis development. Study Design The sample consisted of 145 individuals with CHR who completed
-
Schizophrenia Quality of Life Scale and Schizophrenia Quality of Life Scale Revision 4: A Systematic Review of Measurement Properties Schizophr. Bull. (IF 5.3) Pub Date : 2024-07-22 Milena Zúñiga Le-Bert, Max Wiessner, Sophia Wehr, Lucia Weigel, Stefan Leucht
Background and Hypothesis Schizophrenia is a severe mental disorder that has a significant impact on quality of life (QOL). Measuring QOL can offer insights into treatment efficacy and areas of intervention, highlighting the importance of valid tools assessing QOL in people with schizophrenia. Study Design We employed the COSMIN systematic review guideline to assess the psychometric properties of the
-
The Prediction of Diagnostic Change From Bipolar Disorder to Schizophrenia and Schizophrenia to Bipolar Disorder in a Population-Based, Longitudinal, National Swedish Sample Schizophr. Bull. (IF 5.3) Pub Date : 2024-07-22 Kenneth S Kendler, Linda Abrahamsson, Jan Sundquist, Kristina Sundquist
Background and Hypothesis To clarify, in a large, representative, longitudinal sample, the rate and predictors of diagnostic conversion from Bipolar Disorder (BD) to Schizophrenia (SZ) and from SZ→BD. Design From individuals born in Sweden 1950–1995 and living there in 1970 or later, we identified at least one initial diagnoses of SZ (n = 8449) and BD (n = 8438) followed for a minimum of 10 and a mean
-
Clozapine Safety in Pregnancy: A Clinical Study Schizophr. Bull. (IF 5.3) Pub Date : 2024-07-20 Jayashri Kulkarni, Adam De Chellis, Heather Gilbert, Emmy Gavrilidis, Eveline Mu, Leila Karimi, Qi Li
Background and Hypothesis Pregnant women with persistent schizophrenia and related disorders may require ongoing antipsychotic treatment, including clozapine. However, the potential risks of using clozapine during pregnancy and the postnatal period remain uncertain. Study Design We conducted a nested case-control study using the National Register of Antipsychotic Medication in Pregnancy (NRAMP) database
-
Reasons for Discharge in a National Network of Early Psychosis Intervention Programs Schizophr. Bull. (IF 5.3) Pub Date : 2024-07-20 Peter L Phalen, William R Smith, Nev Jones, Samantha J Reznik, C Nathan Marti, John Cosgrove, Molly Lopez, Monica E Calkins, Melanie E Bennett
Background Discharge from early psychosis intervention is a critical stage of treatment that may occur for a variety of reasons. This study characterizes reasons for discharge among participants in early psychosis intervention programs participating in the Early Psychosis Intervention Network (EPINET) which comprises >100 programs in the United States organized under 8 academic hubs. Study Design We
-
Making Sense of Recovery From First Psychosis With Antipsychotic Medication: A Qualitative Phenomenological Study Schizophr. Bull. (IF 5.3) Pub Date : 2024-07-15 Stéphanie Astrid Dijkstra, Jennifer Rijkeboer, Arjen Noordhof, Lindy-Lou Boyette, Steven Berendsen, Mariken de Koning, Romy Liza Japien Bennen, Tim Hofman, Lieuwe de Haan
Background and Hypothesis Recovering from a first psychosis is a highly individual process and requires the person to make sense of their experiences. Clinicians, in turn, need to comprehend these first-person perspectives, creating a mutual sense-making dynamic. Antipsychotic medication is a substantial part of psychosis treatment. Providing insight in the lived experience of recovery with antipsychotics
-
Schizophrenia-Like Deficits and Impaired Glutamate/Gamma-aminobutyric acid Homeostasis in Zfp804a Conditional Knockout Mice Schizophr. Bull. (IF 5.3) Pub Date : 2024-07-11 Qiao-xia Zhang, Shan-shan Wu, Peng-jie Wang, Rui Zhang, Robert K Valenzuela, Shan-shan Shang, Ting Wan, Jie Ma
Background and Hypothesis Zinc finger protein 804A (ZNF804A) was the first genome-wide associated susceptibility gene for schizophrenia (SCZ) and played an essential role in the pathophysiology of SCZ by influencing neurodevelopment regulation, neurite outgrowth, synaptic plasticity, and RNA translational control; however, the exact molecular mechanism remains unclear. Study Design A nervous-system-specific
-
Associations of Cognitive Expectancies With Auditory Hallucinations and Hallucinatory-Like Experiences in Patients With Schizophrenia Schizophr. Bull. (IF 5.3) Pub Date : 2024-07-10 Joachim Kowalski, Małgorzata Dąbkowska, Adrianna Aleksandrowicz, Michał Jarkiewicz, Frank Larøi, Łukasz Gawęda
Background Various neurocognitive models explore perceptual distortions and hallucinations in schizophrenia and the general population. A variant of predictive coding account suggests that strong priors, like cognitive expectancy, may influence perception. This study examines if stronger cognitive expectancies result in more auditory false percepts in clinical and healthy control groups, investigates
-
Neuroimage Analysis Methods and Artificial Intelligence Techniques for Reliable Biomarkers and Accurate Diagnosis of Schizophrenia: Achievements Made by Chinese Scholars Around the Past Decade Schizophr. Bull. (IF 5.3) Pub Date : 2024-07-10 Yuhui Du, Ju Niu, Ying Xing, Bang Li, Vince D Calhoun
Background and Hypothesis Schizophrenia (SZ) is characterized by significant cognitive and behavioral disruptions. Neuroimaging techniques, particularly magnetic resonance imaging (MRI), have been widely utilized to investigate biomarkers of SZ, distinguish SZ from healthy conditions or other mental disorders, and explore biotypes within SZ or across SZ and other mental disorders, which aim to promote
-
Evaluating Reduced Blood Monitoring Frequency and the Detection of Hematological Abnormalities in Clozapine-Treated Patients With Schizophrenia: A Chart Review Study From the COVID-19 Pandemic Schizophr. Bull. (IF 5.3) Pub Date : 2024-07-10 Helen Thai, Nicholas Preobrazenski, TiChen Hsieh, Carrie Robertson, Olabisi Owoeye
Background and Hypothesis In response to Health Canada’s March 2020 directive, patients on clozapine for over 12 months were allowed to extend hematological testing intervals from 4 to 8 weeks during the COVID-19 pandemic. We hypothesized that this change would not affect the timely detection of hematological abnormalities in patients with severe mental illness. Study Design A chart review was conducted
-
A 10-Year Longitudinal Study of Brain Cortical Thickness in People with First-Episode Psychosis Using Normative Models Schizophr. Bull. (IF 5.3) Pub Date : 2024-07-06 Pierre Berthet, Beathe C Haatveit, Rikka Kjelkenes, Amanda Worker, Seyed Mostafa Kia, Thomas Wolfers, Saige Rutherford, Dag Alnaes, Richard Dinga, Mads L Pedersen, Andreas Dahl, Sara Fernandez-Cabello, Paola Dazzan, Ingrid Agartz, Ragnar Nesvåg, Torill Ueland, Ole A Andreassen, Carmen Simonsen, Lars T Westlye, Ingrid Melle, Andre Marquand
Background Clinical forecasting models have potential to optimize treatment and improve outcomes in psychosis, but predicting long-term outcomes is challenging and long-term follow-up data are scarce. In this 10-year longitudinal study, we aimed to characterize the temporal evolution of cortical correlates of psychosis and their associations with symptoms. Design Structural magnetic resonance imaging
-
Association of Positive, Negative, and Disorganized Schizotypy With the Temporal Dynamics of Schizotypic Experiences in Daily Life Schizophr. Bull. (IF 5.3) Pub Date : 2024-07-04 Kathryn C Kemp, Sarah H Sperry, Laura Hernández, Neus Barrantes-Vidal, Thomas R Kwapil
Background and Hypothesis Schizotypy is a useful and unifying construct for examining the etiology, development, and expression of schizophrenia-spectrum psychopathology. The positive, negative, and disorganized schizotypy dimensions are associated with distinct patterns of schizophrenia-spectrum symptoms and impairment. Furthermore, they are differentiated by mean levels of psychotic-like, suspicious
-
National Institute of Mental Health Support for Cognitive Treatment Development in Schizophrenia: A Narrative Review Schizophr. Bull. (IF 5.3) Pub Date : 2024-06-28 Robert K Heinssen, Sarah E Morris, Joel T Sherrill
For several decades the National Institute of Mental Health (NIMH) has supported basic and translational research into cognitive impairment in schizophrenia. This article describes the Institute’s ongoing commitment to cognitive assessment and intervention research, as reflected by three signature initiatives—Measurement and Treatment Research to Improve Cognition in Schizophrenia; Cognitive Neuroscience
-
Psychosocial Interventions for Individuals With Comorbid Psychosis and Substance Use Disorders: Systematic Review and Meta-analysis of Randomized Studies Schizophr. Bull. (IF 5.3) Pub Date : 2024-06-28 Salsabil Siddiqui, Dhvani Mehta, Alexandria Coles, Peter Selby, Marco Solmi, David Castle
Background and Hypothesis Substance use is highly prevalent among people with schizophrenia (SCZ) and related disorders, however, there is no broad-spectrum pharmacotherapy that concurrently addresses both addiction and psychotic symptoms. Psychosocial (PS) interventions, which have yielded promising results in treating psychosis and substance dependence separately, demonstrate potential but have not
-
Intact Serial Dependence in Schizophrenia: Evidence from an Orientation Adjustment Task Schizophr. Bull. (IF 5.3) Pub Date : 2024-06-27 David Pascucci, Maya Roinishvili, Eka Chkonia, Andreas Brand, David Whitney, Michael H Herzog, Mauro Manassi
Background and Hypothesis For a long time, it was proposed that schizophrenia (SCZ) patients rely more on sensory input and less on prior information, potentially leading to reduced serial dependence—ie, a reduced influence of prior stimuli in perceptual tasks. However, existing evidence is constrained to a few paradigms, and whether reduced serial dependence reflects a general characteristic of the
-
Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder Schizophr. Bull. (IF 5.3) Pub Date : 2024-06-20 Mary F Brunette, Robert M Roth, Christi Trask, Jibran Y Khokhar, James C Ford, Soo Hwan Park, Sara M Hickey, Thomas Zeffiro, Haiyi Xie
Background and Hypothesis Up to 43% of people with schizophrenia have a lifetime cannabis use disorder (CUD). Tetrahydrocannabinol (THC) has been shown to exacerbate psychosis in a dose-dependent manner, but little research has assessed its effects on schizophrenia and co-occurring CUD (SCZ-CUD). In this double-dummy, placebo-controlled trial (total n = 130), we hypothesized that a modest dose of THC
-
Unraveling NEK4 as a Potential Drug Target in Schizophrenia and Bipolar I Disorder: A Proteomic and Genomic Approach Schizophr. Bull. (IF 5.3) Pub Date : 2024-06-13 Chengcheng Zhang, ZhiHui Yang, Xiaojing Li, Liansheng Zhao, Wanjun Guo, Wei Deng, Qiang Wang, Xun Hu, Ming Li, Pak Chung Sham, Xiao Xiao, Tao Li
Background and Hypothesis Investigating the shared brain protein and genetic components of schizophrenia (SCZ) and bipolar I disorder (BD-I) presents a unique opportunity to understand the underlying pathophysiological processes and pinpoint potential drug targets. Study Design To identify overlapping susceptibility brain proteins in SCZ and BD-I, we carried out proteome-wide association studies (PWAS)
-
Genetic Implication of Prenatal GABAergic and Cholinergic Neuron Development in Susceptibility to Schizophrenia Schizophr. Bull. (IF 5.3) Pub Date : 2024-06-13 Darren Cameron, Ngoc-Nga Vinh, Parinda Prapaiwongs, Elizabeth A Perry, James T R Walters, Meng Li, Michael C O’Donovan, Nicholas J Bray
Background The ganglionic eminences (GE) are fetal-specific structures that give rise to gamma-aminobutyric acid (GABA)- and acetylcholine-releasing neurons of the forebrain. Given the evidence for GABAergic, cholinergic, and neurodevelopmental disturbances in schizophrenia, we tested the potential involvement of GE neuron development in mediating genetic risk for the condition. Study Design We combined
-
Comparative Efficacy and Acceptability of Treatment Strategies for Antipsychotic-Induced Akathisia: A Systematic Review and Network Meta-analysis Schizophr. Bull. (IF 5.3) Pub Date : 2024-06-13 Yuki Furukawa, Kota Imai, Yusuke Takahashi, Orestis Efthimiou, Stefan Leucht
Background Antipsychotics are the treatment of choice for schizophrenia, but they often induce akathisia. However, comparative efficacy of treatment strategies for akathisia remains unclear. Design We performed a systematic review and network meta-analyses (PROSPERO CRD42023450720). We searched multiple databases on July 24, 2023. We included randomized clinical trials comparing 1 or more treatment
-
The Association Between Chronic Tobacco Smoking and Brain Alterations in Schizophrenia: A Systematic Review of Magnetic Resonance Imaging Studies Schizophr. Bull. (IF 5.3) Pub Date : 2024-06-02 Merel Koster, Lilli Mannsdörfer, Marieke van der Pluijm, Lieuwe de Haan, Tim Ziermans, Guido van Wingen, Jentien Vermeulen
Background and Hypothesis The high co-occurrence of tobacco smoking in patients with schizophrenia spectrum disorders (SSD) poses a serious health concern, linked to increased mortality and worse clinical outcomes. The mechanisms underlying this co-occurrence are not fully understood. Study Design Addressing the need for a comprehensive overview of the impact of tobacco use on SSD neurobiology, we
-
Hallucination Proneness Alters Sensory Feedback Processing in Self-voice Production Schizophr. Bull. (IF 5.3) Pub Date : 2024-06-02 Suvarnalata Xanthate Duggirala, Michael Schwartze, Lisa K Goller, David E J Linden, Ana P Pinheiro, Sonja A Kotz
Background Sensory suppression occurs when hearing one’s self-generated voice, as opposed to passively listening to one’s own voice. Quality changes in sensory feedback to the self-generated voice can increase attentional control. These changes affect the self-other voice distinction and might lead to hearing voices in the absence of an external source (ie, auditory verbal hallucinations). However
-
Brain Age Gap in Early Illness Schizophrenia and the Clinical High-Risk Syndrome: Associations With Experiential Negative Symptoms and Conversion to Psychosis Schizophr. Bull. (IF 5.3) Pub Date : 2024-05-31 Jessica P Y Hua, Samantha V Abram, Rachel L Loewy, Barbara Stuart, Susanna L Fryer, Sophia Vinogradov, Daniel H Mathalon
Background and Hypothesis Brain development/aging is not uniform across individuals,spawning efforts to characterize brain age from a biological perspective to model the effects of disease and maladaptive life processes on the brain. The brain age gap represents the discrepancy between estimated brain biological age and chronological age (in this case, based on structural magnetic resonance imaging
-
Functional Connectivity-Based Searchlight Multivariate Pattern Analysis for Discriminating Schizophrenia Patients and Predicting Clinical Variables Schizophr. Bull. (IF 5.3) Pub Date : 2024-05-31 Yayuan Chen, Sijia Wang, Xi Zhang, Qingqing Yang, Minghui Hua, Yifan Li, Wen Qin, Feng Liu, Meng Liang
Background Schizophrenia, a multifaceted psychiatric disorder characterized by functional dysconnectivity, poses significant challenges in clinical practice. This study explores the potential of functional connectivity (FC)-based searchlight multivariate pattern analysis (CBS-MVPA) to discriminate between schizophrenia patients and healthy controls while also predicting clinical variables. Study Design
-
Unraveling the Concept of Childhood Adversity in Psychosis Research: A Systematic Review Schizophr. Bull. (IF 5.3) Pub Date : 2024-05-30 Sjur S Sætren, Jone R Bjørnestad, Akiah A Ottesen, Helen L Fisher, Daniel A S Olsen, Kari Hølland, Wenche ten Velden Hegelstad
Background During the last decades, an abundance of studies has investigated childhood adversity in relation to psychosis. This systematic review critically examines the methodologies employed to investigate childhood adversity in psychosis over the past decade, including operational definitions, measurement tools and characteristics, and psychometric properties of instruments used in these studies
-
Unraveling the Prefrontal Cortex-Basolateral Amygdala Pathway’s Role on Schizophrenia’s Cognitive Impairments: A Multimodal Study in Patients and Mouse Models Schizophr. Bull. (IF 5.3) Pub Date : 2024-05-30 Jiaquan Liang, Lei Chen, Yongbiao Li, Yuewen Chen, Lin Yuan, Yue Qiu, Shuangshuang Ma, Fangcheng Fan, Yong Cheng
Background and Hypothesis This study investigated the role of the medial prefrontal cortex (mPFC)-basolateral amygdala (BLA) pathway in schizophrenia (SCZ)-related cognitive impairments using various techniques. Study Design This study utilized clinical scales, magnetic resonance imaging, single-cell RNA sequencing, and optogenetics to investigate the mPFC-BLA pathway in SCZ patients. In the mouse
-
Aberrant Cardiac Interoception in Psychosis Schizophr. Bull. (IF 5.3) Pub Date : 2024-05-24 Jayson Jeganathan, Megan E J Campbell, Nicolas Legrand, Micah Allen, Michael Breakspear
Background and Hypothesis There is mounting evidence that cardiac interoception, the perception of one’s heartbeat, is central to affective experiences. It has been proposed that symptoms of psychosis could arise from interoceptive dysfunction. Here we hypothesized that people with psychotic disorders would have a specific impairment in cardiac interoception, over and above broader perceptual deficits
-
The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study Schizophr. Bull. (IF 5.3) Pub Date : 2024-05-24 Vera Brink, Humma Andleeb, Charlotte Gayer-Anderson, Celso Arango, Manuel Arrojo, Domenico Berardi, Miquel Bernardo, Julio Bobes, Cristina Marta Del-Ben, Laura Ferraro, Lieuwe de Haan, Daniele La Barbera, Caterina La Cascia, Antonio Lasalvia, Pierre-Michel Llorca, Paolo Rossi Menezes, Baptiste Pignon, Julio Sanjuán, José Luis Santos, Jean-Paul Selten, Ilaria Tarricone, Andrea Tortelli, Giada Tripoli
Background and Hypothesis Recent findings suggest the incidence of first-episode psychotic disorders (FEP) varies according to setting-level deprivation and cannabis use, but these factors have not been investigated together. We hypothesized deprivation would be more strongly associated with variation in FEP incidence than the prevalence of daily or high-potency cannabis use between settings. Study
-
Thinking About the Future of Cognitive Remediation Therapy Revisited: What Is Left to Solve Before Patients Have Access? Schizophr. Bull. (IF 5.3) Pub Date : 2024-05-23 Til Wykes, Christopher R Bowie, Matteo Cella
In our previous paper on the Future of Cognitive Remediation published more than 10 years ago, we envisaged an imminent and wide implementation of cognitive remediation therapies into mental health services. This optimism was misplaced. Despite evidence of the benefits, costs, and savings of this intervention, access is still sparse. The therapy has made its way into some treatment guidance, but these
-
Advancements and Future Directions in Prevention Based on Evaluation for Individuals With Clinical High Risk of Psychosis: Insights From the SHARP Study Schizophr. Bull. (IF 5.3) Pub Date : 2024-05-14 TianHong Zhang, LiHua Xu, YanYan Wei, HuiRu Cui, XiaoChen Tang, YeGang Hu, YingYing Tang, ZiXuan Wang, HaiChun Liu, Tao Chen, ChunBo Li, JiJun Wang
Background and Hypothesis This review examines the evolution and future prospects of prevention based on evaluation (PBE) for individuals at clinical high risk (CHR) of psychosis, drawing insights from the SHARP (Shanghai At Risk for Psychosis) study. It aims to assess the effectiveness of non-pharmacological interventions in preventing psychosis onset among CHR individuals. Study Design The review
-
The Complex Latent Structure of Attenuated Psychotic Symptoms: Hierarchical and Bifactor Models of SIPS Symptoms Replicated in Two Large Samples at Clinical High Risk for Psychosis Schizophr. Bull. (IF 5.3) Pub Date : 2024-05-10 Henry R Cowan, Trevor F Williams, Vijay A Mittal, Jean Addington, Carrie E Bearden, Kristin S Cadenhead, Tyrone D Cannon, Barbara A Cornblatt, Matcheri Keshevan, Diana O Perkins, Daniel H Mathalon, William Stone, Scott W Woods, Elaine F Walker
Background and Hypothesis The Structured Interview for Psychosis-Risk Syndromes (SIPS) and other assessments of psychosis risk define clinical high risk for psychosis (CHR) by the presence of attenuated psychotic symptoms. Despite extensive research on attenuated psychotic symptoms, substantial questions remain about their internal psychometric structure and relationships to comorbid non-psychotic
-
Validation of an ICD-Code-Based Case Definition for Psychotic Illness Across Three Health Systems Schizophr. Bull. (IF 5.3) Pub Date : 2024-05-10 Anthony J Deo, Victor M Castro, Ashley Baker, Devon Carroll, Joseph Gonzalez-Heydrich, David C Henderson, Daphne J Holt, Kimberly Hook, Rakesh Karmacharya, Joshua L Roffman, Emily M Madsen, Eugene Song, William G Adams, Luisa Camacho, Sarah Gasman, Jada S Gibbs, Rebecca G Fortgang, Chris J Kennedy, Galina Lozinski, Daisy C Perez, Marina Wilson, Ben Y Reis, Jordan W Smoller
Background and Hypothesis Psychosis-associated diagnostic codes are increasingly being utilized as case definitions for electronic health record (EHR)-based algorithms to predict and detect psychosis. However, data on the validity of psychosis-related diagnostic codes is limited. We evaluated the positive predictive value (PPV) of International Classification of Diseases (ICD) codes for psychosis.